The Newsroom

Investigations  /  08.16.2010

Robbins Umeda LLP Announces an Investigation of the Acquisition of Trubion Pharmaceuticals, Inc. by Emergent Biosolutions Inc.


Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Trubion Pharmaceuticals, Inc. (“Trubion” or the “Company”) (NASDAQ: TRBN) in connection with their efforts to sell Trubion to Emergent Biosolutions Inc. (“Emergent”) (NYSE: EBS).  If the transaction is completed, Trubion shareholders will receive $1.365 in cash and 0.1641 shares of Emergent common stock for each share of Trubion they hold, for an implied value of approximately $4.40 per share.  Trubion shareholders will also receive one Contingent Value Right per share, which will entitle the holder to receive cash payments based upon achievement of predefined milestones.  The transaction is expected to close in the fourth quarter of 2010.

Robbins Umeda LLP’s investigation concerns whether the Board of Directors of Trubion undertook a fair process to obtain fair consideration for all shareholders of Trubion.  Specifically, our investigation concerns whether the Company’s Board of Directors breached their fiduciary duties to Trubion shareholders by failing to adequately shop the Company before entering into the transaction with Emergent.  Notably, at least one analyst has set a price target for Trubion of $7.00 per share, $2.60 higher than the implied value of Emergent’s offer.  Additionally, even if Emergent hits all the predefined milestones, the consideration is still below the analyst target.

If you are a shareholder of Trubion, plan to continue to hold your shares, and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsarroyo.com.

Shareholder Information







Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.
I have read the disclaimer information.



Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns